Endovia Health Sciences, Inc.
EDVA- Exchange
- NYSE
- Industry
- Beverages
- SEC CIK
- 0001553788
No open-market purchases or sales by Endovia Health Sciences, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $172.1K in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Endovia Health Sciences, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 0 | 9 | +9 |
| Shares | 0 | 279.1K | +279.1K |
| Value | $0 | $1.01M | +$1.01M |
New holders (9)
Institutions that held Endovia Health Sciences, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| FNY Investment Advisers, LLC | 104,400 | $378.0K | 0.15% |
| Verition Fund Management LLC | 50,000 | $182.0K | 0.00% |
| Shay Capital LLC | 50,000 | $182.0K | 0.04% |
| Parsons Capital Management Inc | 43,249 | $157.0K | 0.01% |
| Virtu Financial LLC | 23,120 | $84.0K | 0.01% |
| UBS Group AG | 4,975 | $18.0K | 0.00% |
| Morgan Stanley | 1,750 | $6.00K | 0.00% |
| BDO Wealth Advisors, LLC | 1,527 | $6.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 100 | $0 | 0.00% |
Sold out (0)
Institutions that held Endovia Health Sciences, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
None.